Tuesday, November 24, 2009, 5:26am EST - Canadian Markets open in 4 hours and 4 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Repligen Corp. (RGEN)

On Nov 23: 4.80 USD   0.00 (0.00%)  
MORE ON RGEN
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Repligen Corporation (NGM:RGEN) Delayed quote dataEdit
Last Trade: 4.80 USD
Trade Time: Nov 23
Change: 0.00 (0.00%)
Prev Close: 4.80
Open: N/A
Bid: N/A
Ask: 5.49 x 500
1y Target Est: 8.00
Day's Range: N/A - N/A
52wk Range: 3.41 - 5.85
Volume: 0
Avg Vol (3m): 80,015.4
Market Cap: 147.64M
P/E (ttm): 3.66
EPS (ttm): 1.31
Div & Yield: N/A (N/A%)
Repligen Corp. (RGEN)
1d  5d  3m  6m  1y  2y  5y  max 
 Add RGEN to Portfolio   Download Data

HEADLINES
"Black Friday" deals may not signal retail comeback
Reuters (Mon 2:54pm)
REPLIGEN CORP Financials
EDGAR Online Financials (Wed, Nov 11)
UPDATE - Regeneron, Sanofi, expand drug partnership
at Reuters (Tue, Nov 10)
New Star Analyst Rankings for Repligen Corporation
StarMine (Sun, Nov 8)
Repligen Corp. F2Q09 (Qtr. End 09/30/09) Earnings Call Transcript
at Seeking Alpha (Thu, Nov 5)
Repligen Q2 Fiscal Year 2010 Earnings Call scheduled for 10:00 am ET today
CCBN (Thu, Nov 5)
REPLIGEN CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
EDGAR Online (Thu, Nov 5)
Repligen Q2 Fiscal Year 2010 Earnings Release - Before Market Open
CCBN (Thu, Nov 5)
Repligen Reports Second Quarter Fiscal Year 2010 Financial Results
PRNewswire (Thu, Nov 5)
Repligen to Present at the Merriman Curhan Ford 6th Annual Investor Summit Tuesday, November 10th, 1:40 p.m. EST
PRNewswire (Tue, Nov 3)
More Headlines for RGEN...

ANALYST
EPS Est (next year) (Mar-08) : N/A
EPS Est (in 2 years) (Mar-09) : N/A
Avg Rec (current)*: 1.0
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Repligen Corporation, a biopharmaceutical company, engages in the research and development of therapeutics for the treatment of central nervous system diseases.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News Canadian Indices